Newscast – Page 130 – media

FDA releases new guidelines for 3D printing devices

The U.S. Food and Drug Administration (FDA) has issued new guidelines related to the 3D printing of medical devices. FDA is now preparing for a significant wave of new technologies that are nearly certain to transform medical practice.
- Source: biospectrumasia
- 624
- December 27, 2017
3D printing FDA medical device polices
High Performance Computing and Big Data in Medicine and Pathology

Innovative data processing technologies allow for new form of medicine, called Personalized or Precision Medicine (PerMed), which is using information about a person’s genes, proteins, and environment to prevent, diagnose and treat diseases. Each type of cancer has its own genetic makeup, giving each tumor cell and tissue a unique character with specific tendencies and vulnerabilities.
- Source: europa
- 743
- December 26, 2017
PerMed Researches
Self-Powered Paper Patch Help Diabetics Measure Glucose During Exercise

A new paper-based sensor patch developed by researchers at Binghamton University, State University of New York could allow diabetics to effectively measure glucose levels during exercise.
- Source: mindsofmalady
- 552
- December 26, 2017
blood glucose levels Researches sensor
Theranos gets $100 million in debt financing to carry it through 2018, with some caveats

Theranos has secured $100 million in debt financing. Yes, someone gave the blood testing company known for handing out questionable test results money.
- Source: Techcrunch
- 414
- December 26, 2017
blood testing debt financing Market Views
Janssen buys into Legend’s CART therapy

Janssen has entered into a global collaboration and license agreement with Legend Biotech USA and Legend Biotech Ireland to develop, manufacture and commercialise experimental CART-cell therapy LCAR-B38M.
- Source: Pharmatimes
- 453
- December 26, 2017
CAR-T therapy Company Insight Market Views
FDA clears Shire’s dosing software for haemophilia A SHARE

Irish biotechnology firm Shire has received 510(k) marketing clearance for its myPKFiT for ADVATE [Antihemophilic Factor (Recombinant)] software from the US Food and Drug Administration (FDA).
- Source: medicaldevice-network
- 651
- December 26, 2017
ADVATE FDA haemophilia A Shire
Seasonal flu kills up to 650,000 worldwide every year, study shows

Seasonal flu kills between 291,000 and 646,000 people worldwide every year, a new analysis of data from 47 countries suggested Wednesday.
- Source: news.mb
- 460
- December 26, 2017
Researches Seasonal flu
Health System CIOs Are Ready to Take mHealth to the Next Level

With some three-quarters of the nation’s health systems now having an mHealth communications strategy, CIOs are now setting their sights on integrating those platforms with clinical decision support tools, including the EHR.
- Source: mhealthintelligence
- 728
- December 25, 2017
CIO mHealth Researches
Clinicians still struggle to quickly access EHRs at point of care

Computers and workstations on wheels (WoWs) were designed to help clinicians spend less time working from nursing-station desktops and more time at the point of care. The reality, however, is that the ideal has yet to be fully realized. All too often care team workflows remain fragmented because of the need to access patient data and clinical information from multiple disparate systems.
- Source: healthcareitnews
- 528
- December 25, 2017
Clinical EHR Researches WoWs
What to know about allergy shots

Allergy shots are how allergen immunotherapy is commonly administered. This method is a proven way of treating reactions to allergens.
- Source: medicalnewstoday
- 612
- December 25, 2017
Allergy immunotherapy

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.